B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

PPP1CA

MOLECULAR TARGET

protein phosphatase 1 catalytic subunit alpha

UniProt: P62136NCBI Gene: 549913 compounds

PPP1CA (protein phosphatase 1 catalytic subunit alpha) is targeted by 13 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting PPP1CA

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Anthralin1.102
2Hexachlorophene1.102
3Mometasone Furoate1.102
4Oxytetracycline1.102
5Thyroxine0.691
6Tannins Polyphenolic compounds with molecular weights of around 500-3000 daltons and containing enough hydroxyl groups (1-2 per 100 MW) for effective cross linking of other compounds (ASTRINGENTS).0.691
7Aurintricarboxylic Acid0.691
8Calcimycin0.691
9Chlorhexidine0.691
10Clotrimazole0.691
11Fluspirilene0.691
12Tetracycline0.691
13Thyroxine0.691

About PPP1CA as a Drug Target

PPP1CA (protein phosphatase 1 catalytic subunit alpha) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 13 compounds with documented PPP1CA interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

PPP1CA inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.